They are important soil organisms, where they contribute to the mineralization of, for example, aromatic compounds. Multidrugresistant acinetobacter baumannii clone, france. We report the first outbreak of carbapenemresistant ndm1producing acinetobacter baumannii in europe, in a french intensivecare unit in january to may 20. Acinetobacter baumannii is an important nosocomial pathogen that causes a variety of diseases, such as pneumonia, skin and soft tissue infections, meningitis and. Genome sequence analysis of an extensively drugresistant. Acinetobacter baumannii is a cause of healthcareassociated infections. Pdf outbreak of ndm1producing acinetobacter baumannii. Objective of this study was to investigate nosocomial a. Habitat and morphology of acinetobacter baumannii online. Contamination of ambient air with acinetobacter baumannii on. Systematic search and quality assessment were performed to select eligible studies reporting one of the following outcomes. It has excellent colonizing potential, and contact transmission is a big challenge intermittent as well as endemic outbreaks. Infections due to resistant acinetobacter baumannii isolates cause difficulties in treatment. Acinetobacter species are oxidasenegative, exhibit twitching motility, and occur in pairs under magnification.
Under the microscope, it looks halfway between a rod and a ball. Acinetobacter baumannii is an aerobic, nonlactose fermenting, oxidasenegative, gramnegative coccobacillus that is most commonly. Contamination of ambient air with acinetobacter baumannii. The aim of this study was to evaluate the susceptibilities of genotypically different a. Acinetobacter baumannii resistance trends in children in. Mar 14, 2010 acinetobacter baumannii is emerging infectious diseases resistant to several antibiotics early diagnosis and optimal treatment can reduce morbidity and mortali. Healthcare provider information sheet for acinetobacter. Multidrugresistant acinetobacter baumannii mdrab causes wound and bloodstream infections as well as ventilatorassociated pneumonia. Aug 23, 2019 trends in antimicrobial resistance help inform infection control efforts. Carbapenems, sulbactam, and colistin are the most effective antibiotics. One study showed that capsular polysaccharides are involved. Comparison of colistin and colistinsulbactam for the. December application of bacteriophagecontaining aerosol against nosocomial transmission of carbapenemresistant acinetobacter baumannii in an intensive care unit yuhuai ho 0 1 chunchieh tseng 1 lihshinn wang 0 1 yiting chen 1 guanjin ho 1 teng yi lin 1 lingyi wang 1 likuang chen 1 0 division of infectious diseases, department of internal medicine, buddhist tzu chi general hospital and.
Jane buckle phd, rn, in clinical aromatherapy third edition, 2015. Acinetobacter species are oxidasenegative, exhibit twitching motility, and occur in pairs under magnification they are important soil organisms, where they contribute to the mineralization of, for example, aromatic compounds. Antimicrobial susceptibilities of clinical acinetobacter. Acinetobacter baumannii is an increasingly problematic hospitalassociated opportunistic pathogen. Apr 15, 2008 multidrugresistant acinetobacter baumannii is recognized to be among the most difficult antimicrobialresistant gramnegative bacilli to control and treat. Acinetobacter baumannii published on dec 20 by american association of neurological surgeons. The bacterium acinetobacter baumannii is a recognized cause of healthcareassociated illness, including pneumonia, bacteremia, and urinary tract infections utis. Acinetobacter is a genus of gramnegative bacteria belonging to the wider class of gammaproteobacteria.
Acinetobacter baumannii is a typically short, almost round, rodshaped coccobacillus gramnegative bacterium. Biofilm formation is mediated by csu pili, assembled via the archaic chaperoneusher pathway. In addition to causing severe disease in hospitalized patients, a. While there are many species of acinetobacter that can cause human disease, acinetobacter baumannii a. December application of bacteriophagecontaining aerosol against nosocomial transmission of carbapenemresistant acinetobacter baumannii in an intensive care unit yuhuai ho 0 1 chunchieh tseng 1 lihshinn wang 0 1 yiting chen 1 guanjin ho 1 teng yi lin 1 lingyi wang 1 likuang chen 1 0 division of infectious diseases, department of internal medicine, buddhist tzu chi general hospital. Acinetobacter baumannii is an aerobic, nonfermentative, gramnegative, nonmotile, coccobacilli harboring a number of effective virulence factors. The incidence of multidrugresistant acinetobacter baumannii mdr a. Structural basis for acinetobacter baumannii biofilm. Acinetobacter baumannii is an opportunistic bacterial pathogen primarily associated with hospitalacquired infections. Multiple sequence types responsible for healthcare. It is a frequent cause of pneumonia and septicemia in immunocompromised patients.
It has excellent colonizing potential, and contact transmission is a. Acinetobacter baumannii specifically targets moist tissues such as mucous membranes or areas of the skin that are exposed, either through accident or injury acinetobacter baumannii is found only rarely as part of the normal skin microflora, with one. The xray structure of the csuccsue chaperoneadhesin preassembly complex reveals the. The major compound, fimsbactin a, was isolated from low. Spychala, timothy cleary, nicholas namias, daniel h. Antibioticresistant infectious bacteria currently imply a high risk and therefore constitute a strong challenge when treating patients in hospital settings. May 22, 2018 nosocomial infections and infections of indwelling devices are major healthcare problems worldwide. Antimicrobial susceptibility of acinetobacter baumannii. Isolates were collected prospectively between 01 20 and 05 20. Acinetobacter baumannii bmc infectious diseases biomed central.
The relevance of acinetobacter baumannii as a problematic microorganism in inpatient. Acinetobacter baumannii an overview sciencedirect topics. Of the 6 airclinical isolate pairs available, 4 pairs were closely related according to reppcr. The antimicrobial resistance profiles and carbapenemase gene content were determined for a collection of colistin andor tigecyclineresistant carbapenemaseproducing a. Burden of multidrugresistant acinetobacter baumannii.
Following their traditional role, the two component systems tcss present in a. Outer membrane protein, oma87 prevents acinetobacter. The air was acinetobacter positive for an average of 21% of the days. Acinetobacter baumannii resistance trends in children in the. Increased blaoxa23like prevalence in acinetobacter baumannii at a tertiary care center in lebanon 2007 20. Recently, we described a situation in which carbapenemresistant a.
Defining genephenotype relationships in acinetobacter. However, there is no experimental evidence demonstrating that a. These infections are strongly associated with the ability of pathogens to form biofilms on biotic and abiotic surfaces. We analyzed antimicrobial susceptibility of nonduplicate isolates in hospitalized patients not limited to hospitalacquired infections in the us bd insights research database. Acinetobacter spp aspectos microbiologicos, clinicos y. Shimose, eriko masuda, maroun sfeir, ana berbel caban, maria x. An optimal therapy for the treatment of pneumonia caused by drugresistant acinetobacter baumannii remains unclear. Acinetobacter baumannii is a gramnegative, opportunistic pathogen. Guide to the elimination of acinetobacter baumannii in long term care facilities, apic 2010 pdf antibiotic resistance threats in the united states, 20, centers for disease control and prevention pdf oregon hai website. Umgang mit patienten mit multiresistentem acinetobacter baumannii. While other species of the genus acinetobacter are often found in. Signal transduction proteins in acinetobacter baumannii.
Increasing antimicrobial resistance among acinetobacter isolates has been documented, although definitions of multidrug resistance vary in the literature. Acinetobacter baumannii, a nonfermenter gramnegative coccobacillus, was considered a lowcategory pathogen in the past, but has now emerged as a leading cause of hospital and communityacquired infections. In the intensive care setting, acinetobacter baumannii causes ventilatorassociated pneumonia and other nosocomial infections that are difficult to treat. Characterization of these species and of particular strains is a priority for the establishment of diagnostic tests and preventive procedures. Participants were requested to fill in a short questionnaire with demographic data age, gender, source of isolation i. Acinetobacter baumannii strain m2 produces type iv pili. Molecular identification of tigecycline and colistin. Acinetobacter baumannii is emerging infectious diseases resistant to several antibiotics early diagnosis and optimal treatment can reduce morbidity and mortali. Trends in resistant enterobacteriaceae and acinetobacter. Structure and biosynthesis of fimsbactins af, siderophores. We examined trends in resistance for enterobacteriaceae and acinetobacter spp. Dec 07, 2014 infections due to resistant acinetobacter baumannii isolates cause difficulties in treatment. Application of bacteriophagecontaining aerosol against. Acinetobacter baumannii is an increasingly worrying organism in the healthcare setting, due to its multidrug resistance and persistence.
Acinetobacter baumannii is an opportunistic pathogen that is a source of nosocomial infections, mostly pneumonia. Treatment options for infections caused by carbapenemresistant. Biofilm formation in acinetobacter baumannii new microbiologica. Sulbactam shows high efficacy against acinetobacter species in vitro and in vivo 4 6. Acinetobacter baumannii, acinetobacter pittii, acinetobacter nosocomialis, and acinetobacter calcoaceticus are grouped as the acinetobacter calcoaceticusbaumannii complex abc as they are mutually closely related and are difficult to be distinguished from each other by phenotypic properties. Acinetobacter baumannii, a nonmotile, glucose non fermentative, oxidase negative, encapsulated, gramnegative coccobacillus, has recently gained importance because of its increasing resistance to the available antibiotics. Acinetobacter baumannii is an aerobic, nonlactose fermenting, oxidasenegative, gramnegative coccobacillus that is most commonly found associated with healthcare environments. It resists many classes of antibiotics by virtue of chromosomemediated genetic elements on. Jul 01, 20 acinetobacter baumannii, acinetobacter pittii, acinetobacter nosocomialis, and acinetobacter calcoaceticus are grouped as the acinetobacter calcoaceticus baumannii complex abc as they are mutually closely related and are difficult to be distinguished from each other by phenotypic properties. Acinetobacter baumannii ab prevention solutions designed. Acinetobacter pittii and acinetobacter nosocomialis among.
Trends in antimicrobial resistance help inform infection control efforts. Systematic search and quality assessment were performed to select eligible studies reporting one of the following. Ribot em, fair ma, gautom r, cameron dn, hunter sb. Keywords abar4, acinetobacter baumannii, gc1, iran, tehran, tn2006, antibiotic resistance, carbapenem resistance, genomic island, global clone 1, oxa23, oxa72 a cinetobacter baumannii is a gramnegative opportunistic pathogen that causes a range of nosocomial infections. Acinetobacter positive patients had their ambient air tested for up to 10 consecutive days. A centers for disease control and prevention cdc report, antimicrobial resistance threats in. In spite of its clinical relevance, until recently, there have been few studies. Acinetobacter isolates often demonstrate resistance to multiple classes of antimicrobial drugs, leading to treatment challenges. The respiratory tract, blood, pleural fluid, urinary tract, surgical wounds, cns, skin and eyes may be sites for infection or colonization. Carbapenems, sulbactam and colistin seem to be the most effective antibiotics for treatment 3. Acinetobacter baumannii is a bacterium that can cause a range of diseases. Rates of infection with hospitalacquired acinetobacter baumannii have exploded over the past decade due to our inability to limit persistence and effectively treat disease. It can also colonize or live in a patient without causing infections or symptoms, especially in respiratory secretions sputum or open wounds. We report a cluster of highly resistant acinetobacter baumannii that occurred in a burn icu over 5 months and then spread to a separate icu.
Nosocomial acinetobacter baumannii infections and changing. Acinetobacter baumannii maintains its virulence after long. Acinetobacter baumannii ein krankenhauskeim mit beunruhigendem entwicklungspotenzial. Antibioticresistant acinetobacter baumannii increasing.
It rapidly acquires antibiotic resistance, leading to the spread of multidrugresistant strains impervious to nearly all antibiotic treatments 1 3. Accumulation of antibiotic resistance genes in carbapenem. The treatment of acinetobacter baumannii infections is difficult. Acinetobacter baumannii ist typi scherweise 3mrgn, wenn alle drei antibiotikagruppen au. This study aims to compare various antimicrobial strategies and to determine the most effective therapy for pneumonia using a network metaanalysis. Acinetobacter baumannii is a notorious pathogen in health care settings around the world, primarily due to high resistance to antibiotics. Acinetobacter baumannii is one of the most clinically significant multidrugresistant organisms in intensive care units icus worldwide 1, 2, with the hospital environment serving as a major reservoir 3 5. Acinetobacter baumannii is an increasing cause for multidrugresistant nosocomial infections, with the potential to rival mrsa. In this retrospective analysis, patients 16 yearsold who received iv colistin or colistinsulbactam for the treatment of mdr a.
Pdf acinetobacter baumannii, a nonmotile, glucose non fermentative, oxidase. Prolonged hospitalisation, immunocompromised patients and excessive antibiotic exposure all contribute to increasing the risk of a. Carbapenemnonsusceptible acinetobacter baumannii, 8 us. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant.
Acinetobacter baumannii has emerged as a medically important pathogen because of the increasing number of infections produced by this organism over the preceding three decades and the global spread of strains with resistance to multiple antibiotic classes. It typically infects people inside a healthcare facility doctors refer to these as nosocomial infections. Department of virology, bacteriology infection control, parasitology mycology, assistance publique hopitaux. Panantibioticresistant acinetobacter baumannii is one of the most troublesome pathogens, capable of colonizing medical devices by means of csu pili, an adhesive organelle that. To compare clinical and microbiological efficacy of colistin and colistinsulbactam for the treatment of multidrugresistant mdr acinetobacter baumannii vap in intensive care units icus. Acinetobacter is a gramnegative bacterium commonly found in soil and water. In spite of its clinical relevance, until recently, there have been few studies addressing the factors that contribute to the pathogenesis. Two case patients developed infections classified as community acquired under standard epidemiological definitions, but wgs revealed clonality, highlighting the risk of burn patients for earlyonset.
Pdf outbreak of ndm1producing acinetobacter baumannii in. Frequencies and incidence densities per 1,000 patientdays of esblproducing k. Acinetobacter baumannii can cause infections in the blood, urinary tract, and lungs pneumonia, or in wounds in other parts of the body. Acinetobacter baumanniia leading cause of nosocomial infectionshas a remarkable capacity to persist in hospital environments and medical devices due to its ability to form biofilms. Novel chatecholhydroxamate siderophores named fimsbactins were identified in acinetobacter baumannii atcc 17978 and acinetobacter baylyi adp1. It can be an opportunistic pathogen in humans, affecting people with compromised immune systems, and is becoming increasingly important as a hospitalderived infection. Outer membrane protein, oma87 prevents acinetobacter baumannii infection iraj rasooli1,2,5 raziyeh abdolhamidi1 abolfazl jahangiri3 shakiba darvish alipour astaneh4 accepted. An alarming increase in the resistance rates of tigecycline and colistin among carbapenemaseproducing acinetobacter baumannii recovered from a greek hospital over a 3year period 2011 20 was investigated.
Acinetobacter baumannii is the most common human pathogen of the genus, and it is well known for its ability to resist desiccation and persist in the environment, which facilitates transmission in healthcare settings. Concomitant contamination of air and environmental surfaces volume 37 issue 7 luis a. Between and, acinetobacter species were the only forms provided by the authors are available with the full text of this article at go to. Drug treatment for multidrugresistant acinetobacter.
1167 500 1414 529 865 1227 131 819 388 386 1361 1197 658 1308 458 247 870 185 1275 1114 143 820 1411 122 219 557 340 557 816 171